Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Latest filing published 10 Feb 2026 for Dynavax Technologies CORP.
Insider track record
Disclosed buys
0
Disclosed sells
17
Signal history
No signal scores available.
Kelly MacDonald: trading record in brief
This profile gathers the share dealings of Kelly MacDonald across 2 companies, led by Ironwood Pharmaceuticals Inc and Dynavax Technologies Corp. We count 41 filings; the first trade dates from 9 July 2019 and the latest from 10 February 2026.
The open-market record consists of 17 sales worth €390k, with no purchase. Other entries cover 12 share grants and 9 option exercises.
The latest filing, published on 10 February 2026, reports a share grant in Dynavax Technologies Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kelly MacDonald
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
60,204 sharesCommon StockSEC:0001781117-26-000002:0
37,500 sharesCommon StockSEC:0001628280-25-058992:0
15,477 sharesCommon StockSEC:0001029142-25-000055:0
16,000 sharesCommon StockSEC:0001029142-25-000035:0
5,333 sharesCommon StockSEC:0001029142-25-000022:0
5,333 sharesCommon StockSEC:0001209191-24-003196:0
5,334 sharesCommon StockSEC:0001209191-23-014170:0
7 of 7 declarations
